Dabur, a leading Indian consumer goods company, has taken Patanjali Ayurved, a rival company, to court over an advertisement for its Chyawanprash product. The advertisement, which claims that Patanjali’s Chyawanprash is the “original” and “authentic” version of the traditional Ayurvedic medicine, has been deemed misleading by Dabur. Dabur has been producing Chyawanprash for over 80 years and claims that Patanjali’s product is a copycat. The company has filed a lawsuit against Patanjali, seeking an injunction to stop the advertisement and damages for trademark infringement. The dispute highlights the intense competition in the Indian consumer goods market, particularly in the traditional medicine segment. The case is likely to be closely watched by industry observers and could have implications for the way companies promote their products in the future.
